MPX International (STU:2J6) Debt-to-Revenue : 3.13 (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is MPX International Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

MPX International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €5.95 Mil. MPX International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2022 was €12.18 Mil. MPX International's annualized Revenue for the quarter that ended in Mar. 2022 was €5.80 Mil. MPX International's annualized Debt-to-Revenue for the quarter that ended in Mar. 2022 was 3.13.

MPX International Debt-to-Revenue Historical Data

The historical data trend for MPX International's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MPX International Debt-to-Revenue Chart

MPX International Annual Data

Trend

Sep18

Sep19

Sep20

Sep21

Debt-to-Revenue

14.93

1.20

3.43

2.60

MPX International Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Debt-to-Revenue	Get a 7-Day Free Trial												1.68	2.38	3.50	3.27	3.13

Competitive Comparison of MPX International's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where MPX International's Debt-to-Revenue falls into.

MPX International Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

MPX International's Debt-to-Revenue for the fiscal year that ended in Sep. 2021 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(4.837	+	7.738)	/	4.837
	=	2.60

MPX International's annualized Debt-to-Revenue for the quarter that ended in Mar. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(5.949	+	12.176)	/	5.796
	=	3.13

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2022) Revenue data.

MPX International Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of MPX International's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MPX International (STU:2J6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MPX International Corp (STU:2J6) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4

Website

https://www.mpxinternationalcorp.com

MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.

MPX International (STU:2J6) Headlines

No Headlines